ArticleCancers2021

Serum sCD25 Protein as a Predictor of Lack of Long-Term Benefits from Immunotherapy in Non-Small Cell Lung Cancer: A Pilot Study.

Anna Siemiątkowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.